Activist Investor Forces P&G's Hand: Shareholder Vote On Joining Board
This article was originally published in The Rose Sheet
Executive Summary
Nelson Peltz's Trian Fund Management, with a stake of around 1.5%, isn't satisfied with P&G progress from multiple initiatives across more than five years toward gaining market share for its health, personal and household care products and increasing margins.
You may also be interested in...
P&G Open To M&A Moves, Closed To Board Seat For Activist Investor
P&G posts 2% organic growth in its latest quarter and its adjusted EPS beat analyst expectations as it is again interested in M&A. A few days after releasing its results, company appeals to shareholders to vote against an activist investor's bid for a board seat.
P&G Open To M&A Moves, Closed To Board Seat For Activist Investor
P&G posts 2% organic growth in its latest quarter and its adjusted EPS beat analyst expectations as it is again interested in M&A. A few days after releasing its results, company appeals to shareholders to vote against an activist investor's bid for a board seat.
P&G Looks To Follow Brand Trimming By Spreading Through M&A
P&G posts 2% organic growth in its latest quarter and its adjusted EPS beat analyst expectations as it is again interested in M&A. However, analysts ask whether P&G, under pressure from an activist investor, has entered a growth era or is pushing a “false positive.”